BioHealth News Archive
What’s next for pharma innovation in China | McKinsey & Company
Three prominent Chinese executives discuss the progress of local companies in drug innovation and the evolving regulatory environment. {iframe}https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/whats-next-for-pharma-innovation-in-china?cid=other-eml-alt-mip-mck-oth-1710&hlkid=7c63407c9d134d0889c3acf8f3b25591&hctky=3027237&hdpid=001a5388-2ecf-4f39-b534-6fdd99bc7190{/iframe}
Read More
Emergent BioSolutions Completes Acquisition of Raxibacumab, an FDA-Approved Anthrax Monoclonal Antibody, From GSK
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has completed its acquisition of raxibacumab, a fully human monoclonal antibody approved by the U.S. Food…
Read More
Sorrento Therapeutics Appoints Mr. Dorman Followwill And Mr. Dave Lemus To The Board Of Directors | Markets Insider
Effective September 26, 2017, the Board of Directors (the "Board") of Sorrento Therapeutics, Inc. (Nasdaq: SRNE) appointed each of Dorman Followwill and David Lemus…
Read More
Science – from Academia to Innovation: Perspectives from Israel
The MIDC and ScienceAbroad, the organization of Israeli scientists abroad, jointly present a revealing program on the bio-tech entrepreneurial ecosystem of Israel and how…
Read More
2017 Technology Showcase | ACG National Capital
When: October 25, 2017 7:30 AM - 12 PM Where: MITRE 7525 Colshire Drive McLean, VA 22102 United States The Technology Showcase emphasizes the…
Read More
Visbiome probiotic approved for IBS in Canada – Healio
Health Canada has approved the probiotic Visbiome as a Natural Health Product for treating symptoms of irritable bowel syndrome in adults and children aged…
Read More
Emergent BioSolutions Announces Closing of New $200 Million Senior Secured Credit Facility | Seeking Alpha
Emergent BioSolutions Inc. (EBS) today announced that it has completed a new five-year, $200 million syndicated senior secured credit facility. This new facility replaces…
Read More
Department of Defense Releases 2018 Broad Agency Announcements for Extramural Medical Research Funding
This Funding Opportunity Announcement is a Broad Agency Announcement (BAA). It is continuously open for a 5-year period, from October 1, 2017 through September…
Read More
Organ-on-a-Chip lab workshops, 3D neuronal application note and the 3-lane OrganoPlate
Next month, we will start a series of workshops for academic scientists. If you always wanted to learn Organ-on-a-Chip techniques, you can now do…
Read More
REGENXBIO Responds to Notification of a Superior Proposal Under Its Merger Agreement With Dimension Therapeutics
REGENXBIO Inc. (Nasdaq:RGNX) today announced that Dimension Therapeutics, Inc. (Nasdaq:DMTX) notified REGENXBIO that it has determined that it has received a “superior proposal” as…
Read More
CureSearch Announces Catapult Impact Fund Award
CureSearch for Children’s Cancer announced the application launch for a $2 million to $5 million (USD) Catapult Impact Fund Award opportunity. The award will…
Read More
A look at Johns Hopkins new connected health accelerator M-1 Ventures – MedCity News
Johns Hopkins Technology Ventures kicked off its inaugural cohort of healthcare startups last month with a focus on connected health and fitness. Called M-1 Ventures,…
Read More
Sisu Global Health’s Hemafuse got regulatory approval in Kenya, Ghana – Technical.ly Baltimore
Sisu Global Health is entering product launch phase in a pair of African countries. The company recently received regulatory clearance to sell its blood…
Read More
Protenus Leadership to Bring Healthcare Cybersecurity Expertise to New America Foundation
Protenus, the health care industry's most robust, analytics-driven solution for detecting inappropriate activity in the electronic health record, is excited to announce that its…
Read More
Sucampo Pharmaceuticals Announces FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with Priority Review Designation Nasdaq:SCMP
Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its…
Read More